Compugen Ltd. (CGEN): The stock ticks all the boxes for top investors – Invest Chronicle
Home  »  News   »  Compugen Ltd. (CGEN): The stock ticks all the boxe...

Compugen Ltd. (CGEN): The stock ticks all the boxes for top investors

For the readers interested in the stock health of Compugen Ltd. (CGEN). It is currently valued at $1.70. When the transactions were called off in the previous session, Stock hit the highs of $1.78, after setting-off with the price of $1.73. Company’s stock value dipped to $1.70 during the trading on the day. When the trading was stopped its value was $1.73.Recently in News on May 16, 2022, Compugen Reports First Quarter 2022 Results. Triple blockade of PVRIG/TIGIT/PD-1 may be required to optimize clinical responses. You can read further details here

Compugen Ltd. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $4.6400 on 01/04/22, with the lowest value was $1.6600 for the same time period, recorded on 05/11/22.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.


Compugen Ltd. (CGEN) full year performance was -78.48%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Compugen Ltd. shares are logging -81.52% during the 52-week period from high price, and 2.41% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $1.66 and $9.20.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 752809 for the day, which was evidently lower, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Compugen Ltd. (CGEN) recorded performance in the market was -60.47%, having the revenues showcasing -43.71% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 152.46M, as it employees total of 73 workers.

Specialists analysis on Compugen Ltd. (CGEN)

During the last month, 0 analysts gave the Compugen Ltd. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.

According to the data provided on, the moving average of the company in the 100-day period was set at 2.9669, with a change in the price was noted -2.94. In a similar fashion, Compugen Ltd. posted a movement of -63.36% for the period of last 100 days, recording 955,504 in trading volumes.

Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for CGEN is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.

Trends and Technical analysis: Compugen Ltd. (CGEN)

Raw Stochastic average of Compugen Ltd. in the period of last 50 days is set at 2.09%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 4.30%. In the last 20 days, the company’s Stochastic %K was 6.45% and its Stochastic %D was recorded 12.19%.

Now, considering the stocks previous presentation, multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -60.47%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -63.12%, alongside a downfall of -78.48% for the period of the last 12 months. The shares increased approximately by -12.37% in the 7-day charts and went up by -26.41% in the period of the last 30 days. Common stock shares were lifted by -43.71% during last recorded quarter.

Leave a Comment

Your email address will not be published.

On Key

Related Posts